97
Views
14
CrossRef citations to date
0
Altmetric
Review

Treatment options for severe sepsis and septic shock

&
Pages 395-403 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sarah C Campbell, Michael G Spigarelli, Joshua Courter & Catherine MT Sherwin. (2013) Metabolic and toxicological considerations for sepsis drug treatments. Expert Opinion on Drug Metabolism & Toxicology 9:1, pages 79-89.
Read now
Giuseppe A Marraro. (2009) Treatment of septic shock and use of drotrecogin alfa (activated) in children. Expert Review of Anti-infective Therapy 7:7, pages 769-772.
Read now

Articles from other publishers (12)

Sun-Young Kwon, MyungJa Ro & Jae-Hong Kim. (2019) Mediatory roles of leukotriene B4 receptors in LPS-induced endotoxic shock. Scientific Reports 9:1.
Crossref
Marwa Y. Sallam, Sahar M. El-Gowilly, Hanan M. El-Gowelli, Mohammed A. El-Lakany & Mahmoud M. El-Mas. (2018) Additive counteraction by α7 and α4β2-nAChRs of the hypotension and cardiac sympathovagal imbalance evoked by endotoxemia in male rats. European Journal of Pharmacology 834, pages 36-44.
Crossref
Fatemeh Fattahi & Peter A. Ward. (2017) Complement and sepsis-induced heart dysfunction. Molecular Immunology 84, pages 57-64.
Crossref
Damian L. Clarke, Jennifer A. Chipps, Benn Sartorius, John Bruce, Grant L. Laing & Petra Brysiewicz. (2016) Mortality rates increase dramatically below a systolic blood pressure of 105-mm Hg in septic surgical patients. The American Journal of Surgery 212:5, pages 941-945.
Crossref
S. Lv, M. Han, R. Yi, S. Kwon, C. Dai & R. Wang. (2014) Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis. International Journal of Clinical Practice 68:4, pages 520-528.
Crossref
Peter Newham, Daniel Ross, Peter Ceuppens, Shampa Das, James W. T. Yates, Catherine Betts, Jaimini Reens, Kevin J. Randall, Richard Knight & Jennifer S. McKay. (2013) Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis. Inflammation Research 63:2, pages 149-160.
Crossref
Naoki Aikawa, Tatsuya Maruyama, Takeshi Takahashi, Satoshi Fujimi, Takeshi Yokoyama, Katsunori Yoshihara, Toshiaki Ikeda, Daikai Sadamitsu & Michiru Momozawa. (2013) A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock. Journal of Infection and Chemotherapy 19:5, pages 931-940.
Crossref
James W. T. Yates, Shampa Das, Guy Mainwaring & John Kemp. (2012) Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis. Journal of Pharmacokinetics and Pharmacodynamics 39:6, pages 591-599.
Crossref
Carla Jennewein, Martina Mehring, Nguyen Tran, Patrick Paulus, Pia Alexandra Ockelmann, Katharina Habeck, Kathrina Latsch, Bertram Scheller, Kai Zacharowski & Haitham Mutlak. (2012) The Fibrinopeptide Bβ15-42 Reduces Inflammation in Mice Subjected to Polymicrobial Sepsis. Shock 38:3, pages 275-280.
Crossref
Peter E Morris, Brian Zeno, Andrew C Bernard, Xiangning Huang, Shampa Das, Timi Edeki, Steven G Simonson & Gordon R Bernard. (2012) A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock. Critical Care 16:1, pages R31.
Crossref
Ineke Vanlaere & Claude Libert. (2009) Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock. Clinical Microbiology Reviews 22:2, pages 224-239.
Crossref
Charles James, Leland Rickman & Mark Swancutt. 2007. Trauma. Trauma 1772 1805 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.